Media Statement on the Government of Canada's announcement regarding cannabis edibles
OTTAWA, June 14, 2019 /CNW/ - In response to the Federal Government's announcement on bringing cannabis edibles to the Canadian market, the Canadian Health Food Association has released the following statement:
"Today, the Minister of Health announced the next steps to bring cannabis edibles to the Canadian market. Unfortunately, this is another example of the government taking steps to make it easier to get high and not to get well. There is currently a glaring gap in the market for Canadians who want access to CBD for its non-intoxicating health benefits and for Canada's safe and reputable natural health products industry who are ready and willing to meet these market demands.
Canada has the potential to be a world leader in the multi-billion dollar CBD market, and we're currently missing the boat on innovation in the health sector with a strict focus on the recreational market ? to the detriment of Canada's renowned and regulated natural health products market. The Government continues to ignore the many Canadians wishing to get well, not high."
Helen Long, President, and Dan Demers, Vice-President of the Canadian Health Food Association, are available for industry comment in response to the announcement today.
Geron Corporation , a late-stage clinical biopharmaceutical company, today announced that it will release its first quarter 2024 financial results and business highlights before the market opens on Thursday, May 2, 2024 via press release, which will...
Tilray Brands, Inc. , a leader in the craft beer and cannabis-lifestyle industries, celebrates high honors and awards at the 2024 Craft Brewer's Conference and World Beer Cup. 10 Barrel Brewing won four craft beer awards and 10...
Fusion Pharmaceuticals Inc. , a clinical-stage oncology company focused on developing next-generation radioconjucates (RCs) as precision medicines, today announced that it has filed and is in the process of mailing the management information circular...
In an important step toward driving long-term affordability and access to treatments for chronic and complex conditions, Evernorth Health Services announced that it will have a Humira® biosimilar available for $0 out of pocket for eligible...
Dr. Siva Mohan, Co-Founder and Chief Medical Officer of RazorMetrics, an Austin-based drug cost reduction platform, is the Best Entrepreneur - Health Products & Services Status: Silver Stevie Winner from the American Business Awards.
The Stevie®...
The Board of Directors of Revvity , today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on August 9, 2024 to all shareholders of record at the close of business on July 19, 2024.
About Revvity ...
